<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>T.-T.</given-names>
   </name>
   <name>
    <surname>Yau</surname>
    <given-names>L.-F.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Mi</surname>
    <given-names>J.-N.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.-R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain.</article-title>
  <source>
   <italic>BMC Cancer</italic>
  </source>
  <volume>18</volume>:
  <issue>799</issue>. 
  <pub-id pub-id-type="doi">10.1186/s12885-018-4714-x</pub-id>
  <?supplied-pmid 30089463?>
  <pub-id pub-id-type="pmid">30089463</pub-id>
 </mixed-citation>
</ref>
